Barrientos Stephan, Brem Harold, Stojadinovic Olivera, Tomic-Canic Marjana
Division of Wound Healing and Regenerative Medicine, Department of Surgery, Winthrop University Hospital/Stony Brook University School of Medicine, Mineola, New York.
Wound Repair Regen. 2014 Sep-Oct;22(5):569-78. doi: 10.1111/wrr.12205.
Wound healing is a complex and dynamic biological process that involves the coordinated efforts of multiple cell types and is executed and regulated by numerous growth factors and cytokines. There has been a drive in the past two decades to study the therapeutic effects of various growth factors in the clinical management of nonhealing wounds (e.g., pressure ulcers, chronic venous ulcers, diabetic foot ulcers). For this review, we conducted an online search of Medline/PubMed and critically analyzed the literature regarding the role of growth factors and cytokines in the management of these wounds. We focused on currently approved therapies, emerging therapies, and future research possibilities. In this review, we discuss four growth factors and cytokines currently being used on and off label for the healing of wounds. These include granulocyte-macrophage colony-stimulating factor, platelet-derived growth factor, vascular endothelial growth factor, and basic fibroblast growth factor. While the clinical results of using growth factors and cytokines are encouraging, many studies involved a small sample size and are disparate in measured endpoints. Therefore, further research is required to provide definitive evidence of efficacy.
伤口愈合是一个复杂且动态的生物学过程,涉及多种细胞类型的协同作用,并由众多生长因子和细胞因子执行和调节。在过去二十年中,人们一直致力于研究各种生长因子在难愈合伤口(如压疮、慢性静脉溃疡、糖尿病足溃疡)临床管理中的治疗效果。在本次综述中,我们对Medline/PubMed进行了在线搜索,并批判性地分析了有关生长因子和细胞因子在这些伤口管理中作用的文献。我们重点关注目前已获批的疗法、新兴疗法以及未来的研究可能性。在本综述中,我们讨论了目前正在用于伤口愈合且有适应证外使用情况的四种生长因子和细胞因子。这些包括粒细胞-巨噬细胞集落刺激因子、血小板衍生生长因子、血管内皮生长因子和碱性成纤维细胞生长因子。虽然使用生长因子和细胞因子的临床结果令人鼓舞,但许多研究样本量较小,且测量终点存在差异。因此,需要进一步研究以提供疗效的确切证据。